Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus
Eukaryotic Cell · 2015-11 · 14 (11) · 1073-1080
DOI: 10.1128/ec.00107-15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eukaryotic Cell, 2015-11. Verfasst von Kevin K Fuller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems. Die Arbeit wurde bisher 217-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Low rates of homologous recombination have broadly encumbered genetic studies in the fungal pathogen Aspergillus fumigatus . The CRISPR/Cas9 system of bacteria has recently been developed for targeted mutagenesis of eukaryotic genomes with high efficiency and, importantly, through a mechanism independent of homologous repair machinery. As this new technology has not been developed for use in A. fumigatus , we sought to test its feasibility for targeted gene disruption in this organism. As a proof of principle, we first demonstrated that CRISPR/Cas9 can indeed be used for high-efficiency (25 to 53%) targeting of the A. fumigatus polyketide synthase gene ( pksP ), as evidenced by the generation of colorless (albino) mutants harboring the expected genomic alteration. We further demonstrated that the constitutive expression of the Cas9 nuclease by itself is not deleterious to A. fumigatus growth or virulence, thus making the CRISPR system compatible with studies involved in pathogenesis. Taken together, these data demonstrate that CRISPR can be utilized for loss-of-function studies in A. fumigatus and has the potential to bolster the genetic toolbox for this important pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
- Department of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA jennifer.loros@dartmouth.edu jay.c.dunlap@dartmouth.edu.
- Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA jennifer.loros@dartmouth.edu jay.c.dunlap@dartmouth.edu.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Fuller, K. K., Chen, S., Loros, J. J., & Dunlap, J. C. (2015). Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus. Eukaryotic Cell, 14(11), 1073-1080. https://doi.org/10.1128/ec.00107-15
Vancouver
Fuller KK, Chen S, Loros JJ, Dunlap JC. Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus. Eukaryotic Cell. 2015;14(11):1073-1080. doi:10.1128/ec.00107-15
BibTeX
@article{Fuller2015,
author = {Fuller, Kevin K and Chen, Shan and Loros, Jennifer J and Dunlap, Jay C},
title = {Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus},
journal = {Eukaryotic Cell},
year = {2015},
volume = {14},
number = {11},
pages = {1073--1080},
doi = {10.1128/ec.00107-15}
}
EUVIMED